White Blood Cell Count and the Risk for Coronary Artery Disease in Young Adults by Twig, Gilad et al.
 
White Blood Cell Count and the Risk for Coronary Artery Disease in
Young Adults
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Twig, Gilad, Arnon Afek, Ari Shamiss, Estela Derazne, Dorit
Tzur, Barak Gordon, and Amir Tirosh. 2012. White blood cell
count and the risk for coronary artery disease in young adults.
PLoS ONE 7(10): e47183.
Published Version doi:10.1371/journal.pone.0047183
Accessed February 19, 2015 11:49:54 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10579670
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAWhite Blood Cell Count and the Risk for Coronary Artery
Disease in Young Adults
Gilad Twig
1,2,3*, Arnon Afek
4,5, Ari Shamiss
4,5, Estela Derazne
3,5, Dorit Tzur
3, Barak Gordon
3,5,
Amir Tirosh
2,6*
1Department Medicine ‘B’, Chaim Sheba Medical Center, Tel-Hashomer, Israel, 2The Dr. Pinchas Borenstein Talpiot Medical Leadership Program, Chaim Sheba Medical
Center, Tel-Hashomer, Israel, 3The Israel Defense Forces Medical Corps, Tel-Hashomer, Israel, 4The Chaim Sheba Medical Center Management, Chaim Sheba Medical
Center, Tel-Hashomer, Israel, 5The Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel, 6The Division of Endocrinology, Diabetes and Hypertension, Brigham
and Women’s Hospital, Harvard School of Public Health, Boston, Massachusetts, United States of America
Abstract
Background: The association between white blood cell (WBC) count and coronary artery disease (CAD) is unknown in young
adults. Our objective was to assess the association between WBC count and its changes over time with CAD incidence in the
Metabolic, Life-style and Nutrition Assessment in Young adults (MELANY) study, a cohort of Israeli army personnel.
Methods and Findings: 29,120 apparently healthy young men (mean age; 31.265.5 years) with a normal baseline WBC
count (3,000–12,000 cells/mm
3) were followed during a mean follow up of 7.563.8 years for incidence of CAD. Participants
were screened every 3–5 years using a stress test, and CAD was confirmed by coronary angiography. In a multivariate model
adjusted for age, body mass index (BMI), LDL- and HDL-cholesterol, blood pressure, family history of CAD, physical activity,
diabetes, triglycerides and smoking status, WBC levels (divided to quintiles) above 6,900 cells/mm
3 (quintile 4) were
associated with a 2.17-fold increase (95%CI=1.18–3.97) in the risk for CAD as compared with men in quintile 1
(WBC#5,400 cells/mm
3). When modeled as a continuous variable, a WBC increment of 1000 cells/mm
3 was associated with
a 17.4% increase in CAD risk (HR 1.174; 95%CI=1.067–1.290, p=0.001). A decrease in the WBC level (within the normal
range) during the follow-up period was associated with increased physical activity and decreased triglyceride levels as well
as with reduced incidence of CAD.
Conclusions: WBC count is an independent risk factor for CAD in young adults at values well within the normal range. WBC
count may assist in detecting subgroups of young men at either low or high risk for progression to CAD.
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Introduction
A growing body of evidence suggests that low grade in-
flammation contributes to the development of coronary artery
disease [1]. In recent years, multiple markers of inflammation have
been tested as potential risk factors for the development of CAD
such as IL-6, E-selectin and CRP [2,3]. Yet, none of these
markers, including CRP, are routinely recommended for screen-
ing of apparently healthy subjects with intermediate risk for CAD
[4].
Elevated white blood cell count (WBC) that is well within the
normal range was associated with an increased risk for
developing CAD [5,6], or for the re-occurrence of myocardial
ischemia [7,8]. Yet, its application into CAD risk stratification
in clinical practice is controversial for several reasons. First, the
at-risk WBC cutoff values contain a wide range depending
mostly on the characteristics of the population studied and the
quality of adjustment for other risk factors [9–12]. Second, the
potential interactions of WBC with the ‘classic’ CAD risk factors
are largely unknown. Such interactions are important both for
defining the relative contribution of WBC count to the
development of CAD compared to known risk factors, as well
as for identifying risk factors that can be amplified by low-grade
inflammation. For example, an Australian cohort in middle
aged men showed that WBC count greater than 6,900 cell/
mm
3 nearly doubled the CAD risk in patients with hyper-
triglyceridemia [13]. Finally, most prospective works used
a single rather than repeated WBC count evaluations [10–
12,14–19]. This methodology raised practical questions on
measurement reproducibility and the potential bias by in-
tercurrent medical conditions which are not necessarily attrib-
uted to chronic inflammation and do not impose an excess
cardiovascular risk.
In this study, we have used the comprehensive MELANY
cohort of the Israeli Defense Forces Medical Corps to study
whether WBC count can assist in predicting CAD among young
and apparently healthy men. We report that WBC levels, well
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e47183within the normal range, can reliably predict CAD in young men
independently from the ‘classic’ cardiovascular risk factors.
Research Design and Methods
Study Population
The Metabolic, Life-Style, and Nutrition Assessment in
Young Adults (MELANY) Cohort has been conducted at the
Israel Defense Forces Staff Periodic Examination Center (SPEC)
to which all career service personnel older than 25 years of age
are referred every three to five year as described previously [20–
24]. At each visit to the SPEC, participants completed a detailed
questionnaire assessing demographic, nutritional, lifestyle, and
medical factors. Thereafter, blood samples were drawn after
a 14-hour fast and analyzed. Height, weight and blood pressure
were measured, and a physician at the center performed
a complete physical examination. Primary care for all Israel
Defense Forces personnel between scheduled visits to the center
is obtained at designated military clinics, and all medical
information was recorded in the same central database, thereby
allowing an ongoing, tight, and uniform follow-up.
Included in this study were 37,418 men who had documented
WBC count within the normal range (3,000–12,000 cells/mm
3)a t
their first visit to the SPEC between the years 1995 and 2010. Men
with newly diagnosed CAD at baseline (n=67) or men with
a follow-up shorter than 2 years (n=8,231) were excluded from
analysis. We had data available for 3,968 women in our cohort, of
which only 2 developed CAD, thus excluding the possibility for
meaningful statistical analysis on the predictive value of WBC.
Thus, 29,120 subjects remained with at least one measurement of
WBC count with a follow up period exceeding 2 years. Of these,
18,479 subjects had at least two measurements of WBC (measured
at least 2 years apart) allowing us to perform a sub analysis to
evaluate the effect of repeated WBC measurements on CAD
incidence.
The institutional review board of the Israel Defense Forces
Medical Corps approved this study on the basis of strict
maintenance of participants’ anonymity during database analyses.
Follow-up and Outcome
Participants were followed prospectively from their first visit to
the SPEC (mean age 31.265.5 years). Follow-up ended at the time
of CAD diagnosis, death, retirement from military service or
March 8
th 2011, whichever came first. Mean follow-up was
7.5163.86 years.
The outcome definition for CAD in MELANY was angiogra-
phy-proven stenosis of .50% in at least one coronary artery. Up
to age 35, referral for a diagnostic procedure was based on specific
complaints, and above 35 years of age all participants underwent
a treadmill exercise test (Bruce protocol) in the presence of a board-
certified cardiologist. Endpoints for the exercise test were ST-
segment depression .2 mm in two contiguous leads, measured 80
milliseconds after the J-point, symptoms of angina, exhaustion, or
achievement of the target heart rate. All participants with an
abnormal stress test were referred for coronary angiography.
When the stress test was borderline or when participants reported
angina symptoms without diagnostic ECG changes, stress perfu-
sion thallium-201 imaging was performed, followed by coronary
angiography for participants with a pathological scan. Those
presenting with symptoms of angina and/or MI between SPEC
visits were referred for coronary angiography following consulta-
tion with a board-certified cardiologist.
Statistical Analysis
The cohort population was divided into WBC quintiles and
their baseline characteristics are presented in Table 1. The
median of the quintiles were fit as continuous variables to
estimate the trend of variables across quintiles in a linear
regression model (adjusted R
2=0.99, B=909 cells/mm
3 per
quintile, p=0.001). Cox proportional hazard models were used
to estimate the Hazard Ratios (HR) and 95% confidence
intervals (CI) for developing CAD. Following age-adjustment
(model 1) additional known CAD risk factors were added in
a stepwise manner (Table 2). In model 2, BMI was added to
model 1 as a continuous variable. In model 3, smoking status
(current-smoker, ex-smoker, never smoked) and physical activity
(not active, ,150 min/week, $150 min/week) were added to
model 2 as categorical variables. In model 4, blood pressure
(systolic ,120 and diastolic ,80; systolic $120 and/or diastolic
$80; systolic $130 and/or diastolic $85; systolic $140 and/or
diastolic $90 mmHg) was added as a categorical variable. In
model 5, high-density lipoprotein cholesterol (HDL), low-density
lipoprotein cholesterol (LDL), and serum triglyceride levels were
added to model 4 as continuous variables. In model 6,
occurrence of diabetes (yes/no) or family history of CAD
(yes/no) were added as categorical variables. Log minus log
plots for each variable were inspected to verify the assumption
of proportionality of the hazards. All variables used in the
model were tested for co-linearity using Pearson’s correlation.
The maximal R recorded were 0.37 (triglyceride and BMI) and
0.28 (diastolic blood pressure and BMI). Omnibus tests of model
coefficients were used to assess the relative contribution of the
various variables to the model. In order to evaluate the power
of the models to discriminate events from nonevents we
calculated the area under the receiver operating characteristic
(ROC) curve for each of the variables as well as in
a multivariate model (C statistic). In a sub group analysis of
18,439 participants who had additional WBC measurements,
the study population was divided into tertiles (low, intermediate
and high) of WBC at baseline and once again following the
second measurement. WBC tertiles of the first measurements
were as follow; T1, WBC#5,900 cells/mm
3; T2,
5,900,WBC#7,110; T3, WBC.7,110 cells/mm
3, and the
second measurement tertiles were: T1, WBC#6,000 cells/
mm
3; T2, 6,000,WBC#7,300; T3, WBC.7,300 cells/mm
3.
Therefore, for simplicity and clarity of presentation, we divided
the tertiles of both measurements based on the WBC tertile
range of the first measurement. Hazard ratios for CAD were
estimated for the 9 cross-classified groups in a multivariate
model adjusted for age, BMI, smoking status, physical activity,
systolic and diastolic blood pressure, HDL, LDL, triglycerides,
diabetes status and family history of CAD. The differences in
metabolic parameters between first and second examinations
were compared among the 4 subgroups of WBC (Table 3) with
Dunnet-T3 test post-hoc multiple comparisons test. Reported
values throughout the study are presented as mean6 standard
deviation (SD) unless mentioned otherwise. Analyses were
performed with SPSS statistical software Vers.19.0.
Results
Characteristics of Study Participants
The 29,120 young men participated in this study were divided
into quintiles based on their WBC count at enrollment. Baseline
characteristics are presented in Table 1. Mean WBC count was
6,68161,500 cells/mm
3 (range 3,000–12,000 cells/mm
3) with an
average increment of 909 cells/mm
3 between consecutive quin-
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(BMI), systolic and diastolic blood pressure, triglycerides level,
LDL and rates of current smokers. Physical activity and HDL
were inversely correlated with WBC levels (p,0.001).
WBC Count is an Independent Risk Factor for Developing
CAD
During 218,840 person-years of follow-up, 188 new cases of
coronary artery disease (CAD) were diagnosed. The incidence of
CAD increased linearly across quintiles of WBC, with 17 new
cases diagnosed in the bottom quintile (Q1,WBC of 3,000–
5,400 cells/mm
3) and 68 new cases diagnosed in Q5 (WBC
.7,810 cells/mm
3). In model 1, adjusted for age, the hazard ratio
(HR) for developing CAD was significant in the third quintile (Q3,
6,110,WBC,6,900 cells/mm
3, HR=1.83, 95%CI=1.02–3.29,
p=0.04), reaching an HR of 3.83 in Q5 (95%CI=2.25–6.52,
p,0.001) as compared with Q1 (Table 2). While further
adjustments for BMI (model 2) and smoking status (model 3)
attenuated the risk for CAD, the risk attributed for increased WBC
count remained significantly and independently elevated even in
the multivariate model adjusted for age, BMI, smoking status,
physical activity, blood pressure, HDL, LDL, triglycerides level,
diabetes status and family history of CAD (model 6), starting at
levels .6,910 cells/mm
3 (model 6, HR observed in Q4 vs. Q1,
2.17; 95%CI=1.18–3.97). When WBC count was modeled as
a continuous variable, an increment of 1000 cells/mm
3 in WBC
count was associated with a 17.4% increase in the risk for
developing CAD independently of age, BMI, smoking status,
physical activity, blood pressure, HDL, LDL, triglycerides level,
diabetes status and family history of CAD (HR 1.174;
95%CI=1.067–1.290, p=0.001).
Risk Prediction of CAD in Young Adults using WBC Count
In order to better assess the interrelation between altered blood
lipid profile and WBC, we next studied the joint effect of LDL and
WBC levels in predicting the risk for developing CAD (Fig. 1a).
When LDL levels were cross-classified with WBC tertiles in
a multivariate analysis controlled for all of the covariates used in
model 6, men with LDL level greater than 130 mg/dL who were
also at the upper WBC tertile (WBC.7,110 cells/mm
3) had a 3.4-
fold increase in the risk for CAD (95%CI=1.57–7.32) as
compared to the reference group. However, CAD incidence
among participants with an elevated LDL level (.130 mg/dL) but
with low WBC count (Tertile 1; WBC#5,900 cells/mm
3), was not
significantly greater than the reference group (HR 1.83;
95%CI=0.74–4.49; p=0.18).
We next studied the joint effect of WBC with HDL, triglyceride
level and family history of CAD in multivariate models (Fig. 1b–d).
Similar to the observations with LDL cholesterol, lower WBC
count (WBC#5,900 cells/mm
3) in young adults was again
associated with CAD incidence that was not significantly in-
creased, even in the presence of high triglyceride level
(TG$150 mg/dL, HR=1.62, 95%CI;0.72–3.61, p=0.24), low
HDL (HDL,40 mg/dL, HR=1.00, 95%CI;0.44–2.25, p=0.99),
or positive family history for CAD (HR=1.06, 95%CI;0.25–4.52,
p=0.93) (Fig. 1b–d). Moreover, subjects with WBC at the upper
tertile, even in the absence of high triglyceride levels, low HDL or
positive family history of CAD, had an approximately 2-fold
increase in the risk for CAD (p,0.03 after adjustment for the
Table 1. Baseline characteristics of population cohort.
Quintile of WBC count Q1 Q2 Q3 Q4 Q5
Total or
Average6SD p
N 5,900 5,630 6,449 5,322 5,819 29,210
WBC count (cells/mm
3) 3,000–5,400 5,401–6,100 6,110–6,900 6,910–7,810 7,810–12,000 6,68261,500
Age6SD (years) 30.865.4 31.065.4 31.165.4 31.465.6 30.565.7 31.265.5 NS
BMI (kg/m
2)2 4 . 4 63.4 25.063.6 25.563.8 26.164.0 26.464.0 25.464.0 ,0.001
BMI,25 63% 54% 48% 43% 36% 49%
25#BMI,30 31% 37% 40% 41% 43% 38%
BMI$30 6% 9% 12% 16% 21% 13%
BPSystolic/BPDiastolic 115.5611.9/ 116.5612.2/ 117.2612.4/ 118613.0/ 119.4613.4/ 117.4612.7/
(mean6SD, mm Hg) 73.669.2 74.169.4 74.869.5 75.6610.0 76.2610.1 74.969.7 ,0.001
Fasting glucose level 89.4611.0 90.3612.3 90.7612.8 91.1613.8 92.6617.0 90.8613.5 ,0.001
HDL (mg/dL) 48.2611.3 47.1610.7 46.1610.5 45.4610.6 44.0610.6 46.2610.8 ,0.001
LDL (mg/dL) 113.7632.6 117.4633.1 118.6633.1 121.2634.2 124.7635.2 119.1633.8 ,0.001
Triglycerides (mg/dL) 100.8 111.5 123.3 135.2 153.3 124.7
[25
th;7 5
th] [61;119] [68;134] [73;150] [79;163] [88;187] [71;151] ,0.001
Physically active (%) 40.2 (8.0) 37.4 (8.0) 24.2 (8.2) 23.4 (7.1) 29.9 (6.0) 34.5 (7.5) ,0.001
Positive family history of CAD (%) 5.8 6.2 6.3 6.9 7.4 6.5 NS
Smoking ,0.001
Never 68% 65% 60% 55% 41% 58%
Ex-smoker 13% 14% 15% 13% 11% 13%
Current smoker 19% 21% 25% 32% 48% 29%
Life style, physical and biochemical characteristic data is presented for 29,120 subjects. ‘Physically active’ refers to participants who have self-reported of being
physically active; values in parentheses indicate the percentage of participants in each quintile reporting of at least 150 minutes of physical activity each week.
doi:10.1371/journal.pone.0047183.t001
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(Fig. 1b–d).
Residual Contribution of WBC to CAD Prediction
In order to assess the differential contribution of the various risk
factors to the prediction of CAD, we next calculated the receiver
operating characteristic (ROC) curves for both WBC count as well
as for other, well-validated CAD risk factors. Surprisingly, the area
under the curve (AUC) of the WBC count ROC curve was not
statistically different than that of HDL (0.663 [95%CI=0.625–
0.702] vs. 0.627 [95%CI=0.585–0.668], respectively), BMI
(0.668 [95%CI=0.632–0.704]) or systolic blood pressure (0.603
[95%CI=0.560–0.646]). In a C-statistics analysis, addition of the
covariates in model 6 to the age adjusted model (model 1)
increased the AUC from 0.747 [95%CI=0.720–0.774] to 0.864
[95%CI=0.840–0.892]. In the full multivariate model, addition of
WBC did not significantly increase the AUC (0.868
[95%CI=0.843–0.894]). Of interest, none of the co-variates
when added to the multivariate model could significantly improve
the AUC of the ROC curve (data not shown).
We next assessed the change in -2 log likelihood in a Cox
regression model, which unlike the C-statistics analysis, controls
for variations in the duration of follow-up, with a forward stepwise
addition of the variables (Omnibus test of model coefficients). The
major contributor for the model was age followed by triglyceride
levels, LDL, smoking status, presence of diabetes, family history of
CAD, systolic blood pressure and WBC count. Of interest, BMI,
HDL-cholesterol and physical activity contributed less to the
prediction model as compared to WBC count.
The Value of Repeated WBC Counts as a Risk Factor for
CAD
Of the 29,120 subjects described in Table 1, 18,439 subjects had
at least two WBC counts available, measured at least 2 years apart
(mean 5.761.8 years) with a subsequent follow-up of 9.463.3
years. Of these, 81 participants were diagnosed with CAD during
the follow-up period. As compared with the baseline WBC
Table 2. Hazard ratio for developing coronary artery disease (CAD) across WBC quintiles.
Quintiles of WBC count Q1 Q2 Q3 Q4 Q5 Total or mean6SD
N 5,900 5,630 6,449 5,322 5,819 29,210
WBC count (1000 cells/ml) 3,000–5,400 5,401–6,100 6,110–6,900 6,910–7,810 7,810–12,000 6,68261,500
Total new cases of CAD 17 17 34 52 68 188
Mean follow-up (years) 7.7563.86 7.6863.89 7.5163.85 7.4663.89 7.1563.78 7.5163.86
Person years of follow-up 45,753 43,278 48,442 39,728 41,639 218,840
Incidence per 1000 person years 0.37 0.39 0.7 1.30 1.63 0.86
Model 1- Age adjusted
Hazard ratio 1 1.040 1.839 3.254 3.831
95%CI 0.531–2.038 1.027–3.292 1.881–5.626 2.250–6.523
P 0.908 0.040 ,0.0001 ,0.0001
Model 2- Age and BMI adjusted
Hazard ratio 1 0.976 1.676 2.870 3.184
95%CI 0.498–1.913 0.935–3.004 1.654–4.979 1.856–5.463
P 0.943 0.083 ,0.0001 0.0001
Model 3- Age, BMI, smoking status, physical activity
Hazard ratio 1 0.939 1.550 2.437 2.439
95%CI 0.479–1.840 0.864–2.783 1.399–4.245 1.406–4.232
P 0.854 0.142 0.002 0.002
Model 4- Age, BMI, smoking status, physical activity, systolic and diastolic blood pressure
Hazard ratio 1 0.935 1.527 2.323 2.321
95%CI 0.477–1.833 0.851–2.741 1.332–4.502 1.336–4.033
P 0.845 0.156 0.003 0.003
Model 5- Age, BMI, smoking status, physical activity, systolic and diastolic blood pressure, HDL, LDL, triglycerides
Hazard ratio 1 1.007 1.405 2.193 1.889
95%CI 0.495–2.048 0.743–2.655 1.198–4.015 1.029–3.466
P 0.985 0.296 0.011 0.040
Model 6- Age, BMI, smoking status, physical activity, systolic and diastolic blood pressure, HDL, LDL, triglycerides, diabetes, family history of CAD
Hazard ratio 1 0.983 1.446 2.173 1.837
95%CI 0.483–2.000 0.765–2.732 1.188–3.977 1.002–3.370
P 0.963 0.256 0.012 0.049
Multivariate Cox-regression analysis was used to derive the hazard ratios under different adjustments to lifestyle, physical and biochemical parameters. Results
summarize 29,120 subjects of whom 188 cases of CAD were diagnosed during 218,840 persons-years of follow-up.
doi:10.1371/journal.pone.0047183.t002
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PLOS ONE | www.plosone.org 5 October 2012 | Volume 7 | Issue 10 | e47183measurement, most subjects remained in the same relative tertile
at the second test (57%), and in over 90% of cases the difference
between the second to the first WBC count was less than 2,000
cell/mm
3 (the Pearson’s correlation between first and second tests
was 0.640, p,0.001). As assessed using the full multivariate model,
subjects with a baseline WBC count at the upper two tertiles (T2
or T3) who were found to have a second WBC at the lower tertile
(T1) had a complete reversal of their risk for CAD
(HRT2RT1=0.793 [95%CI; 0.15–3.94, p=0.77],
HRT3RT1=0.857 [95%CI;0.09–7.44, p=0.88]) as compared
with participants who had a low WBC count at both time points
(T1RT1). Subjects who were at the highest WBC tertile throughout
the entire follow-up period have reached over 3-fold increase in
the risk for CAD (HR 3.31; 95%CI;1.35–8.10, p=0.009). The
most recent WBC count (taken at the second time point,
approximately 5 years following baseline measurements) was
found to be an independent risk factor for incident CAD when
added to the full multivariate model (model 6), p=0.041, while the
increased risk attributed to the baseline WBC measurement was
completely attenuated (p=0.831).
We next characterized the participants whom WBC counts at
the second time point has changed between the two extreme
tertiles (T1RT3 or T3RT1, Table 3). Groups were compared to
subjects that remained in the lower or upper tertiles at the two
time points (T1RT1 and T3RT3, respectively). Consistent with the
cohort effect, all groups had a significant increase in BMI from
time 1 (baseline) to time 2 (second measurement of WBC) as well
as a reduction in HDL cholesterol levels. The T3RT1 group had
the lowest weight gain (DBMI=0.762.0 kg/m
2) and the lowest
increase in systolic blood pressure (0.6614.1 mmHg) during
follow-up, (p,0.03 for both, as compared with the other groups).
In addition, the group of participants with an observed decrease in
WBC count from T3 to T1 was the only group that exhibit
a significant decrease in mean triglyceride level from 127.2678.1
to 117.0662.1 mg/dL (p=0.002), while differences in LDL
cholesterol or diastolic blood pressure were similar between
subgroups. Participants demonstrating an increase in WBC count
from the lowest to the highest tertile (T1RT3) had the highest
increase in both weight (DBMI=1.662.1 kg/m
2), systolic and
diastolic blood pressure (D=3.5615.5 and 1.9611.8 mmHg,
Figure 1. The joint effect of WBC tertiles and established risk factors for CAD. WBC tertiles were divided as followed: T1, WBC#5,900 cells/
mm
3; T2, 5,900,WBC#7,110; T3, WBC.7,110 cells/mm
3. The reference group in all tests was T1. Multivariate models were adjusted to age, BMI,
smoking status, physical activity, systolic and diastolic blood pressure, LDL, HDL, triglyceride level, diabetes status and family history of CAD. P value
of interactions for WBC with LDL, triglyceride level or family history of CAD were 0.510, 0.951 and 0.123, respectively. Dark bars indicate p,0.05.
doi:10.1371/journal.pone.0047183.g001
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cerides (D=31.7678.1 mg/dL), (p,0.001 for all).
Discussion
This large-scale follow-up study demonstrated that a single
measurement of WBC in healthy young men may predict CAD
incidence independently from other risk factors for CAD such as
elevated lipids, and a positive family history. WBC level above
6,900 cells/mm
3 was associated with a ,2-fold increase in the risk
for CAD with a significant 17.4% increase in CAD incidence
observed for every increment of 1,000 WBC/mm
3.
Previous studies assessing the relationship between WBC and
CAD incidence are available mainly for middle aged participants
and in the elderly population, with conflicting results. The HRs
reported are usually between 1.1 to 2.0 [10–12,15,16,18] with
a reported ‘threshold’ for excess risk ranging from 6,600 to 9,200
leukocytes/mm
3. Two major contributors to this variability could
be recognized: an inconsistent adjustment to known risk factors
including BMI, diabetes and altered lipid profile [4], and variable
definitions of the cardiovascular outcomes. The definition of
coronary disease in most studies was primarily self-reported or
relied on clinical symptoms using different diagnostic criteria
[5,25]. Furthermore, it is likely that contribution of low-grade
inflammation to CAD development is different along the stages of
plaque formation [18]. Therefore, studying different ages at
various stages in the natural history of atherosclerosis may lead to
different results. It is possible that increased inflammation may be
important at early stages in the natural history of coronary disease,
while later in the course of disease progression, other risk factors
may become more predominant. In this study, we used a pro-
active screening approach in a young and apparently healthy
population, with a unifying and accurate definition of CAD as
assessed by coronary angiography. This allowed us to assess the
role of WBC count relatively early in the course of coronary
atherosclerosis, before symptoms develop as is usually the case at
early ages. In addition, available to us was a comprehensive data
set of other CAD risk factors, thus allowing us to conduct detailed
adjustments to other known risk factors of CAD.
To the best of our knowledge, this is the first study using
consecutive WBC counts rather than a single baseline measure-
ment. In the context of CAD prediction, using multiple WBC
measurements over time may be of benefit. First, the overall good
reproducibility of the results over a period of several years
underlies the validity of WBC count as a marker for chronic
inflammatory burden assessment in healthy individuals. Further-
more, changes in WBC over time were accompanied by changes
in both lifestyle parameters, anthropometric measurements and
other metabolic markers, reflecting a ‘true’ change in CAD risk
profile.
Several limitations of this study warrant consideration. First, the
MELANY cohort may be considered representative of a unique
group of healthy young men. However, the characteristics of the
population are strikingly similar to those of cohorts in published
studies of young men from various industrialized countries [26–
29]. In addition, the relatively homogeneous environment to
which participants in our study were exposed might reduce the
effect of unknown confounders. Second, although they did not
compromise the outcome definition, measurements of WBC
differentials were not obtained in this study, limiting our ability
to assess specifically the role of neutrophiles and monocytes as
potentially more specific predictors for the development of CAD
[25]. In addition, the relatively low rate of CAD incidence in this
age group may compromise the statistical power to conclude for
specific interactions between WBC and additional risk factors, as
well as with repeated measurements of WBC. Furthermore, as
mentioned above, the relevance of the proposed association
between WBC and CAD should also be assessed for clinically
overt cardiovascular outcomes. The strengths of the MELANY
study include the detailed, uniform, and systematic follow-up and
outcome definition; the use of measured (rather than reported)
values for BMI calculation; the availability of reliable determina-
tions of blood tests and the direct measurements of lipids.
In summary, high-normal WBC count, measured in young,
healthy men in an outpatient screening setting, is an independent
and reliable risk factor for CAD. The joint effect of WBC count,
a readily available measurement, with other known risk factors for
CAD may help to better identify young men at either high or low
cardiovascular risk. Additional studies in other, more heteroge-
neous populations as well as in clinically overt cardiovascular
disease are required in order to conclude about the potential use of
WBC as a risk predictor for CAD.
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